Reneo Pharmaceuticals Inc (RPHM)
1.65
-0.03
(-1.79%)
USD |
NASDAQ |
Apr 25, 10:50
Reneo Pharmaceuticals Price to Book Value: 0.6223 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 0.6336 |
| April 23, 2024 | 0.6318 |
| April 22, 2024 | 0.6374 |
| April 19, 2024 | 0.6563 |
| April 18, 2024 | 0.6638 |
| April 17, 2024 | 0.6676 |
| April 16, 2024 | 0.6223 |
| April 15, 2024 | 0.6261 |
| April 12, 2024 | 0.6525 |
| April 11, 2024 | 0.6412 |
| April 10, 2024 | 0.645 |
| April 09, 2024 | 0.6412 |
| April 08, 2024 | 0.6336 |
| April 05, 2024 | 0.645 |
| April 04, 2024 | 0.6525 |
| April 03, 2024 | 0.645 |
| April 02, 2024 | 0.645 |
| April 01, 2024 | 0.6412 |
| March 28, 2024 | 0.6261 |
| March 27, 2024 | 0.6223 |
| March 26, 2024 | 0.6223 |
| March 25, 2024 | 0.6299 |
| March 22, 2024 | 0.6261 |
| March 21, 2024 | 0.6374 |
| March 20, 2024 | 0.6261 |
| Date | Value |
|---|---|
| March 19, 2024 | 0.6223 |
| March 18, 2024 | 0.6186 |
| March 15, 2024 | 0.6261 |
| March 14, 2024 | 0.6035 |
| March 13, 2024 | 0.6072 |
| March 12, 2024 | 0.6035 |
| March 11, 2024 | 0.6072 |
| March 08, 2024 | 0.6261 |
| March 07, 2024 | 0.6186 |
| March 06, 2024 | 0.611 |
| March 05, 2024 | 0.6186 |
| March 04, 2024 | 0.6148 |
| March 01, 2024 | 0.6186 |
| February 29, 2024 | 0.6223 |
| February 28, 2024 | 0.611 |
| February 27, 2024 | 0.6261 |
| February 26, 2024 | 0.6186 |
| February 23, 2024 | 0.6072 |
| February 22, 2024 | 0.6148 |
| February 21, 2024 | 0.611 |
| February 20, 2024 | 0.6186 |
| February 16, 2024 | 0.6223 |
| February 15, 2024 | 0.6299 |
| February 14, 2024 | 0.6299 |
| February 13, 2024 | 0.6223 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3543
Minimum
May 23 2022
3.548
Maximum
May 08 2023
1.153
Average
0.9183
Median
Price to Book Value Benchmarks
| Mirum Pharmaceuticals Inc | 4.429 |
| NovaBay Pharmaceuticals Inc | 1.644 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6933 |
| Theriva Biologics Inc | 0.1647 |
Price to Book Value Related Metrics
| Price | 1.65 |
| Earnings Yield | -153.3% |
| Market Cap | 55.14M |